PMC full text:Copyright/LicenseRequest permission to reuseSince January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
Fig. 2
Disease progression in MERS-CoV infected marmosets. (A) Clinical score of all animals. The animals were observed twice daily for clinical signs of disease and scored using a clinical scoring system prepared for common marmosets (Falzarano et al., 2014). (B) Grading per animal per day was done independently and blinded by two clinical veterinarians. (A/B) Mean values ± SD were calculated. Red = hyperimmune plasma-treated marmosets; Blue = mAb-treated marmosets; Green = control marmosets; ● = 1; ■ = 2; ▲ = 3. (C) Ventral-dorsal and lateral thoracic radiographs as well as gross pathology images of marmosets taken 7 dpi. Shown are animals H3, M1 and C1. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Images in this article
Click on the image to see a larger version.